U.S. Water Utilities Stock News

Earnings miss, higher guidance and new ALS data reshape the Corcept story Corcept Therapeutics (CORT) has given investors a mixed update, pairing a first quarter net loss with higher 2026 revenue guidance and fresh two year survival data from its Phase 2 DAZALS ALS study. The company reported a net loss of US$31.76 million for the quarter ended March 31, 2026, compared with net income of US$20.55 million a year earlier, with basic and diluted loss per share of US$0.30 from continuing...

Arbor Realty Trust (NYSE:ABR) has reset its quarterly dividend as part of a broader push to reduce nonperforming assets and real estate owned. Management is emphasizing faster resolution of troubled loans and a lower REO balance, alongside a growing origination pipeline. The company has highlighted plans that target improved asset quality and earnings in late 2026 and 2027. For income focused investors watching NYSE:ABR, the dividend reset comes after a tough stretch for the stock, with...

In early May 2026, Shopify reported first-quarter 2026 results showing revenue of US$3,170 million and sales of US$2,420 million, alongside a reduced net loss of US$581 million, and subsequently filed a circular urging shareholders to vote against an activist proposal for a formal responsible AI policy ahead of its June 16, 2026 annual meeting. This combination of strong top-line growth with continued losses, plus management’s resistance to a shareholder-backed AI governance policy, raises...

If you are wondering whether Marvell Technology at US$170.84 is priced for perfection or still offers value, the next sections will help you frame that question clearly. The stock has delivered returns of 4.4% over the past week, 33.0% over the last month, 91.1% year to date and 165.6% over the last year, with 3-year and 5-year returns of 310.2% and 306.9% respectively. Recent coverage has focused on Marvell's positioning within the semiconductor sector and how investors are reacting to its...

QuantumScape recently completed installation and start-up of its Eagle Line pilot-scale solid-state cell production facility, reported its first US$11,000,000 in customer billings from ecosystem partners, and delivered a narrower GAAP net loss for Q1 2026 driven by lower operating expenses. This progress marks a shift from pure development toward early commercialization, including an emerging licensing and royalty stream that may reshape how investors view QuantumScape’s business model and...

eXp World Holdings, now trading under the ticker NasdaqGM:AGNT, has acquired franchise based brokerage NextHome. The company is shifting to a multi model real estate platform that offers both cloud brokerage and franchise options for agents and brokers. The new structure brings multiple brands under one global umbrella, with the AGNT ticker reflecting the broader platform focus. For real estate investors, NasdaqGM:AGNT now represents more than a pure cloud brokerage business. The...

In early May 2026, PHINIA Inc. showcased its first homologated hydrogen internal combustion engine light commercial vehicle at ACT Expo in Las Vegas, highlighting lower-carbon technology developed with Aramco that meets Euro 7 standards and targets very large reductions in tailpipe CO2 emissions versus diesel. The company coupled this technology milestone with a solid first-quarter earnings report, higher year-on-year sales and net income, continued 2026 guidance, and completion of a...

D-Market Elektronik Hizmetler ve Ticaret (HEPS) is back on investors’ radar after reporting first quarter 2026 results, with higher sales and gross merchandise value alongside a wider net loss driven by growth investments. See our latest analysis for D-Market Elektronik Hizmetler ve Ticaret. The earnings release appears to have cooled very short term sentiment, with the share price down 2.48% over the last day and 1.43% over the week. However, a 7.42% year to date share price return contrasts...

What Bruker’s recent performance means for investors Bruker (BRKR) has drawn attention after a mixed stretch for the stock, with a gain of about 19% over the past week and an increase of roughly 15% over the past month. See our latest analysis for Bruker. That recent burst of momentum, with an 18.9% 7 day share price return and a 15.1% 30 day share price return to US$43.27, contrasts with a softer year to date share price return and a 3 year total shareholder return that has been weak. As a...

Why Westlake Stock Is Drawing Attention Now Westlake (WLK) is back on investors’ radar after recent share price swings, with the stock up about 4% over the past day but down roughly 18% over the past month. See our latest analysis for Westlake. The recent 1-day share price return of 3.95% comes after a tougher stretch, with the 30-day share price return down 17.58% even as the year-to-date share price return is 31.57% and the 1-year total shareholder return is 16.98%. This points to fading...

NRSInsights data on April same-store sales and transaction values has put a spotlight on IDT (IDT), as investors weigh how this retail activity feeds into the company’s broader communications and fintech operations. See our latest analysis for IDT. At a share price of $52.16, IDT has a 30 day share price return of 5.01% and a 90 day share price return of 6.38%, while the 1 year total shareholder return is down 9.36% and the 5 year total shareholder return is up 103.87%. This indicates that...

In May 2026, Terex Corporation reported first-quarter 2026 results showing sales of US$1,734 million, up from US$1,229 million a year earlier, but a net loss of US$89 million versus prior net income of US$21 million, alongside no share repurchases under its July 2025 authorization and completion of a US$117.16 million buyback launched in December 2022. This combination of stronger revenues with a shift to loss-making operations, plus a pause on the newer repurchase plan, raises fresh...

Oruka Therapeutics (ORKA) stock is drawing attention after a recently completed $700 million common stock offering raised dilution concerns and coincided with volatility around its Halozyme Hypercon collaboration and interim clinical trial updates. See our latest analysis for Oruka Therapeutics. At a latest share price of US$65.68, Oruka’s recent common stock offering, Halozyme Hypercon agreement and interim trial readouts have gone hand in hand with sharp swings, including a 99.76% 3 month...

OneSpaWorld Holdings (OSW) has drawn fresh attention after reporting first quarter earnings, with revenue of US$247.63 million and net income of US$21.33 million, and raising full year revenue guidance. See our latest analysis for OneSpaWorld Holdings. The 1-year total shareholder return of 24.31% and 3-year total shareholder return of 105.87% point to strong long term wealth creation. Meanwhile, the year to date share price return of 16.23% suggests momentum has been building despite a...

Inhibrx Biosciences recently reported positive interim Phase 2 data from the HexAgon study, where its hexavalent OX40 agonist INBRX-106 combined with pembrolizumab produced higher confirmed response rates and more complete responses than pembrolizumab alone in first-line PD-L1 high head and neck cancer patients. These data, supported by strong T-cell activation signals and a generally manageable safety profile, have prompted plans for a Phase 3 trial and broader exploration of INBRX-106...

Universal Technical Institute, Inc. reported past second‑quarter 2026 results with revenue rising to US$221.4 million from US$207.45 million a year earlier, while net income fell to US$0.433 million from US$11.45 million as higher operating and growth-related costs compressed earnings per share from US$0.21 to US$0.01. Management framed this profit squeeze as the result of heavy spending on new campuses and programs, reaffirming full‑year guidance and underscoring a willingness to accept...

Why Veeco’s new Indium Phosphide orders matter for investors Veeco Instruments (VECO) has drawn fresh attention after announcing more than US$250 million in new equipment orders tied to Indium Phosphide laser production for high speed optical transceivers in hyperscale data centers. For you as an investor, the interest here is less about a single headline number and more about what it signals: that Veeco’s tools sit directly in the supply chain for the shift from copper to optical...

Hess Midstream (HESM) reported first quarter 2026 results that showed higher revenue and net income versus the prior year, while also reaffirming full year earnings and operating guidance, a combination many income focused investors watch closely. See our latest analysis for Hess Midstream. Hess Midstream’s recent earnings announcement comes after a steady share price move, with the stock up 13.10% on a year to date share price basis and a 5 year total shareholder return of 140.87%. This...

American Homes 4 Rent (AMH) has drawn investor attention after recent trading, with the stock closing at $32.05. The company operates as a U.S. REIT focused on single family rental homes across multiple states. See our latest analysis for American Homes 4 Rent. Recent trading has been relatively steady, with a 30 day share price return of 7.69% contrasting with a 1 year total shareholder return that declined 13.07%. This indicates that recent momentum has picked up after a weaker stretch. If...

Dominion Energy’s recent quarterly update showed first-quarter 2026 sales rising to US$5,019 million while net income eased to US$621 million, alongside a confirmed quarterly dividend of US$0.6675 per share and a new US$3.00 billion shelf registration for floating rate demand notes with a dividend reinvestment plan. The company’s stronger-than-expected profit and revenue, reaffirmed earnings outlook, and rejection of shareholder proposals on governance and ESG-linked pay together highlight...

In early May 2026, W.W. Grainger reported first-quarter 2026 results showing higher sales of US$4.74 billion and increased net income of US$555 million year over year, raised its full-year 2026 net sales and EPS guidance, and filed a new shelf registration for debt securities. Alongside these results, the company also announced a higher quarterly dividend of US$2.49 per share, extending its multidecade pattern of annual dividend increases and underlining management’s confidence in cash...

Brinker International (EAT) has drawn investor attention after a period of mixed share performance, including a decline of about 10% over the past month and roughly 14% over the past 3 months. See our latest analysis for Brinker International. Zooming out, the recent 10% 1 month share price decline and 14.4% 3 month share price decline contrast sharply with a 3 year total shareholder return of about 266%. This suggests momentum has cooled after a very strong multi year run. If you are...

In early May 2026, Viper Energy reported first-quarter results showing sharply higher production and revenue, updated its 2026 production guidance, completed a US$610 million share repurchase program, and declared both base and variable cash dividends for Class A shareholders. Together with progress on portfolio reshaping and debt reduction, these developments highlight Viper’s emphasis on capital returns while supporting higher expected output from its royalty assets. Next, we’ll assess how...

In early May 2026, Capricor Therapeutics filed a lawsuit against Nippon Shinyaku and NS Pharma seeking to rescind their 2022 U.S. distribution agreement for Deramiocel, alleging pricing flaws and inadequate commercial launch preparations that could restrict patient access to the Duchenne muscular dystrophy therapy. This legal move puts the spotlight on how Capricor plans to control Deramiocel’s commercialization pathway at a critical point in its FDA review and potential future market...